Leerink Partnrs Comments on Bicycle Therapeutics plc’s FY2025 Earnings (NASDAQ:BCYC)
Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) – Investment analysts at Leerink Partnrs issued their FY2025 earnings per share estimates for Bicycle Therapeutics in a report released on Tuesday, February 20th. Leerink Partnrs analyst J. Chang expects that the company will post earnings of ($5.20) per share for the year. The consensus estimate for Bicycle […]
More Stories
Zotefoams (LON:ZTF) Hits New 1-Year Low – Here’s Why
Zotefoams plc (LON:ZTF – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock...
Mineralys Therapeutics (NASDAQ:MLYS) Shares Down 9.6% – Here’s Why
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report)’s stock price traded down 9.6% on Wednesday . The company traded as...
Britvic (LON:BVIC) Hits New 12-Month High – Should You Buy?
Britvic plc (LON:BVIC – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday ....
RBG (LON:RBGP) Sets New 12-Month Low – Time to Sell?
Shares of RBG Holdings plc (LON:RBGP – Get Free Report) hit a new 52-week low during trading on Wednesday ....
Lattice Semiconductor Adopts 2025 Inducement Equity Incentive Plan
Lattice Semiconductor Corporation, a Delaware-based company specializing in semiconductor technology, announced on January 9, 2025, the adoption of the Lattice...
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 3.9% – Here’s What Happened
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report)’s stock price shot up 3.9% during trading on Wednesday . The stock...